Osage Partners

Osage Partners LLC is a private equity and venture capital firm established in 1990, based in Bala Cynwyd, Pennsylvania, with an additional office in Princeton, New Jersey. The firm specializes in early-stage, mid-venture, and late-stage investments, primarily focusing on technology and healthcare sectors. It seeks to invest in a wide range of areas including business-to-business software, life sciences, healthcare IT, medical devices, diagnostics, and advanced materials. Osage Partners typically invests between $1 million to $4 million in companies with annual revenues ranging from $500,000 to $3 million, with a preference for leading investment rounds. The firm emphasizes partnerships with research universities to support startups that commercialize university technologies, having collaborated with over 80 institutions, including many of the top research universities in the U.S. Osage Partners is committed to actively participating in the governance of its portfolio companies to foster growth and innovation.

Robert Adelson

Managing Partner

Anurag Agarwal

Principal

Natasha Azar

VP of Investor Relations and Marketing University Relations

Louis Berneman

Founding Partner

Matthew Cohen Ph.D

Managing Partner, Life Science

Kevin C. Coleman

VP of Acquisitions

Sean Dowling

Principal

David Drahms

Partner

Claudia Dunnous

Chief Financial Officer, Finance

Emily Foote

Principal

Beth Grafstrom

Vice President of Finance

Jon Gulardo

Senior Analyst

Margalit Haber

Associate

Bill Harrington

Managing Partner, Life Science

Nate Lentz

Managing Partner

Nathanael V. Lentz

Managing Partner and Partner

Kirsten Leute

Senior Vice President for University Relations

Marc Singer

Co-Founder & Managing Partner, Technology

Stephanie Stehman

Principal

Manny Stockman Ph.D

Partner, Technology

Past deals in Pennsylvania

Interius BioTherapeutics

Series A in 2021
Interius BioTherapeutics is a biopharmaceutical company that targets cancer. The company spun out the University of Pennsylvania and is targeting cancer.

DrayNow

Series A in 2020
DrayNow, Inc., founded in 2017 and based in Pipersville, Pennsylvania, operates as a technology company specializing in the intermodal freight sector. It offers a real-time online marketplace that connects intermediaries with carriers, facilitating the efficient management of intermodal freight transportation. By leveraging advanced technology, DrayNow enables users to maintain constant visibility of shipments, compare rates, view load details, and select available loads in real-time. This innovative platform optimizes the first and last mile of intermodal logistics, enhancing operational efficiency and helping companies achieve higher levels of capacity, service, and profitability.

Palladio Biosciences

Series B in 2020
Palladio Biosciences, Inc. is a clinical-stage biotechnology company focused on developing transformative medicines for orphan diseases affecting the kidneys. Founded in 2015 and based in Horsham, Pennsylvania, the company is recognized for its work on Lixivaptan, a selective vasopressin V2 receptor antagonist aimed at treating polycystic kidney disease, a serious genetic condition. Palladio Biosciences aims to address unmet medical needs in the field of renal diseases through its innovative therapeutic solutions.

Sidecar

Series C in 2019
Sidecar is an e-commerce marketing company that builds the advanced technology retailers need to optimize cross-channel online shopping campaigns. With a team of data science and e-commerce experts, our state-of-the-art machine learning engine, and a massive volume of data, Sidecar is the magic behind retail's most efficient and powerful online shopping campaigns.

DrayNow

Series A in 2019
DrayNow, Inc., founded in 2017 and based in Pipersville, Pennsylvania, operates as a technology company specializing in the intermodal freight sector. It offers a real-time online marketplace that connects intermediaries with carriers, facilitating the efficient management of intermodal freight transportation. By leveraging advanced technology, DrayNow enables users to maintain constant visibility of shipments, compare rates, view load details, and select available loads in real-time. This innovative platform optimizes the first and last mile of intermodal logistics, enhancing operational efficiency and helping companies achieve higher levels of capacity, service, and profitability.

DrayNow

Series A in 2018
DrayNow, Inc., founded in 2017 and based in Pipersville, Pennsylvania, operates as a technology company specializing in the intermodal freight sector. It offers a real-time online marketplace that connects intermediaries with carriers, facilitating the efficient management of intermodal freight transportation. By leveraging advanced technology, DrayNow enables users to maintain constant visibility of shipments, compare rates, view load details, and select available loads in real-time. This innovative platform optimizes the first and last mile of intermodal logistics, enhancing operational efficiency and helping companies achieve higher levels of capacity, service, and profitability.

Picwell

Series B in 2018
PICWELL INC. operates an online predictive recommendation engine that enables consumers to select their health plan. The company forecasts a consumer's future healthcare needs using lifestyle, behavioral, and financial data, as well as various health claims. It serves exchanges and marketplaces, benefit platforms, lead generators, agents and brokers, retail pharmacies, and employers. The company was incorporated in 2013 and is based in Philadelphia, Pennsylvania.

Wylei

Venture Round in 2017
Wylei provides adaptive content solutions to agencies and brands to increase digital messaging relevance and engagement. It uses advanced predictive algorithms to take the guesswork out of digital web, email, mobile, and video campaigns. Wylei's Adaptive Content(TM) and Predictive Intelligence, delivers emails that adapt to the specific context of open, based on where, how, and when the email is viewed.

Sidecar

Series C in 2017
Sidecar is an e-commerce marketing company that builds the advanced technology retailers need to optimize cross-channel online shopping campaigns. With a team of data science and e-commerce experts, our state-of-the-art machine learning engine, and a massive volume of data, Sidecar is the magic behind retail's most efficient and powerful online shopping campaigns.

TimelinePI

Venture Round in 2017
TimelinePI, Inc. is a company that specializes in developing process and timeline visualization software aimed at enhancing business process understanding and optimization. Founded in 2015 and headquartered in Springfield, Pennsylvania, TimelinePI offers a comprehensive process intelligence platform that provides solutions for business process management, employee journey mapping, IT service management, and procurement. The platform enables automatic processing of various operational data, including order processing, medical patient tracking, and supply chain management, into detailed process timelines. This functionality allows businesses in sectors such as financial services, insurance, and healthcare to monitor and improve productivity and operational efficiency. As of August 2019, TimelinePI operates as a subsidiary of ABBYY USA Software House, Inc.

Verge Aero

Venture Round in 2017
Verge Aero, based in Philadelphia, is a company specializing in the development and operation of drone entertainment systems. Founded in 2014, it comprises a team of engineers with expertise in electrical, computer, software, systems, and aerospace disciplines. The company has created advanced drone performance software that enables the control of drone swarms, allowing for seamless integration with existing entertainment setups. This technology facilitates dynamic interactions between drones, audiences, and performers. Verge Aero's near-term applications include recurring drone performances, venue installations, touring productions, and various drone entertainment products, showcasing the innovative potential of unmanned aerial systems in the entertainment industry.

Merganser Biotech

Venture Round in 2016
Merganser Biotech is a research company that is engaged in the development and licensing of medicines for the treatment of hematological and iron overload diseases that include beta thalassemia and hemochromatosis. The company develops hepcidin mimetic peptides to control iron metabolism and ineffective erythropoiesis. Merganser Biotech was founded 2011 and is based in Newtown Square, Pennsylvania.

Sidecar

Series B in 2015
Sidecar is an e-commerce marketing company that builds the advanced technology retailers need to optimize cross-channel online shopping campaigns. With a team of data science and e-commerce experts, our state-of-the-art machine learning engine, and a massive volume of data, Sidecar is the magic behind retail's most efficient and powerful online shopping campaigns.

PeopleLinx

Series A in 2015
PeopleLinx made selling easy by integrating social into the team's sales process and metrics. PeopleLinx guides sales professionals to build relationships, attract qualified leads, and drive deals using online social networks. Their technology maps to the sales process integrated with CRM, and measures results. PeopleLinx’s customers include Fortune 500 leaders in financial services, high-tech, and professional services. It was founded by early LinkedIn employees in 2009 and is headquartered in Philadelphia, Pennsylvania.

Picwell

Series A in 2015
PICWELL INC. operates an online predictive recommendation engine that enables consumers to select their health plan. The company forecasts a consumer's future healthcare needs using lifestyle, behavioral, and financial data, as well as various health claims. It serves exchanges and marketplaces, benefit platforms, lead generators, agents and brokers, retail pharmacies, and employers. The company was incorporated in 2013 and is based in Philadelphia, Pennsylvania.

Merganser Biotech

Series A in 2015
Merganser Biotech is a research company that is engaged in the development and licensing of medicines for the treatment of hematological and iron overload diseases that include beta thalassemia and hemochromatosis. The company develops hepcidin mimetic peptides to control iron metabolism and ineffective erythropoiesis. Merganser Biotech was founded 2011 and is based in Newtown Square, Pennsylvania.

AppBus

Pre Seed Round in 2015
AppBus, Inc. is a New Jersey-based company that develops a Workplace-as-a-Service platform designed to deliver enterprise functionality on employee-owned devices. The platform integrates, automates, and secures the delivery of enterprise applications across various devices and networks. By leveraging existing enterprise capabilities, AppBus facilitates adaptation to change, enhances transparency in automation, and accelerates the delivery of optimal user experiences. The company aims to foster innovation and improve time-to-value within the enterprise ecosystem, benefiting employees, customers, and partners alike. Formerly known as 51maps INC., AppBus rebranded in July 2016 to reflect its focus on modern workplace solutions.

InstaMed

Venture Round in 2014
InstaMed Communications, LLC is a healthcare payments network that connects providers, payers, and consumers through a secure, cloud-based platform designed for managing healthcare payment transactions. Founded in 2004 and headquartered in Philadelphia, Pennsylvania, InstaMed offers several products, including InstaMed Online for Providers and InstaMed Online for Payers, both of which ensure secure and efficient management of healthcare payments. Additionally, InstaMed Connect allows for the integration of healthcare payments into various healthcare IT applications through its API. The company's technology enhances the healthcare payment experience by driving electronic transactions and facilitating the seamless movement of funds and healthcare data, ultimately improving consumer satisfaction. As of July 2019, InstaMed operates as a subsidiary of JPMorgan Chase Bank.

Wylei

Seed Round in 2014
Wylei provides adaptive content solutions to agencies and brands to increase digital messaging relevance and engagement. It uses advanced predictive algorithms to take the guesswork out of digital web, email, mobile, and video campaigns. Wylei's Adaptive Content(TM) and Predictive Intelligence, delivers emails that adapt to the specific context of open, based on where, how, and when the email is viewed.

PeopleLinx

Series A in 2014
PeopleLinx made selling easy by integrating social into the team's sales process and metrics. PeopleLinx guides sales professionals to build relationships, attract qualified leads, and drive deals using online social networks. Their technology maps to the sales process integrated with CRM, and measures results. PeopleLinx’s customers include Fortune 500 leaders in financial services, high-tech, and professional services. It was founded by early LinkedIn employees in 2009 and is headquartered in Philadelphia, Pennsylvania.

Sidecar

Series A in 2014
Sidecar is an e-commerce marketing company that builds the advanced technology retailers need to optimize cross-channel online shopping campaigns. With a team of data science and e-commerce experts, our state-of-the-art machine learning engine, and a massive volume of data, Sidecar is the magic behind retail's most efficient and powerful online shopping campaigns.

ProtonMedia

Venture Round in 2013
ProtonMedia is a company that specializes in virtual world technology aimed at enterprise collaboration and learning. Its primary product, ProtoSphere, offers a secure and private environment designed for a range of business applications, including e-learning, virtual meetings, and collaborative events. The platform supports various industries, such as pharmaceuticals, medical devices, financial services, and technology, facilitating rich data visualization and enhancing communication for scientific research, sales, and manufacturing efforts. Founded in 1998 and headquartered in Lansdale, Pennsylvania, ProtonMedia continues to provide innovative solutions that enable organizations to engage effectively in a digital workspace.

PeopleLinx

Series A in 2013
PeopleLinx made selling easy by integrating social into the team's sales process and metrics. PeopleLinx guides sales professionals to build relationships, attract qualified leads, and drive deals using online social networks. Their technology maps to the sales process integrated with CRM, and measures results. PeopleLinx’s customers include Fortune 500 leaders in financial services, high-tech, and professional services. It was founded by early LinkedIn employees in 2009 and is headquartered in Philadelphia, Pennsylvania.

Medallion Analytics

Series A in 2012
Medallion Analytics is a web-based solution provider that specializes in the mortgage industry, offering an end-to-end platform that enhances compliance and cost management throughout the loan origination process. Founded in 2009 and headquartered in Pittsburgh, Pennsylvania, the company bridges the gap between loan origination systems and the post-closing environment. Medallion Analytics delivers a suite of productivity tools designed for office automation, enabling users to streamline operations and improve efficiency in managing mortgage processes.

Ceptaris Therapeutics

Series D in 2012
Ceptaris Therapeutics, Inc. is a privately held, specialty pharmaceutical company that is developing a proprietary gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma (CTCL). If approved, Ceptaris' investigational drug would be the first topical mechlorethamine product available to treat the signs and symptoms of this rare cancer.

InstaMed

Venture Round in 2012
InstaMed Communications, LLC is a healthcare payments network that connects providers, payers, and consumers through a secure, cloud-based platform designed for managing healthcare payment transactions. Founded in 2004 and headquartered in Philadelphia, Pennsylvania, InstaMed offers several products, including InstaMed Online for Providers and InstaMed Online for Payers, both of which ensure secure and efficient management of healthcare payments. Additionally, InstaMed Connect allows for the integration of healthcare payments into various healthcare IT applications through its API. The company's technology enhances the healthcare payment experience by driving electronic transactions and facilitating the seamless movement of funds and healthcare data, ultimately improving consumer satisfaction. As of July 2019, InstaMed operates as a subsidiary of JPMorgan Chase Bank.

Carnegie Speech

Series B in 2012
Carnegie Speech Company, Inc., a speech assessment and tutoring software company, provides speech training technology to help to speak English clearly. It offers Carnegie Speech Assessment, which rate the proficiency of spoken English; Native Accent, which teach to pronounce English clearly; and YOUTH Database, a set of recordings of children reading words, phrases, and sentences in English. The company serves BPO and education markets. Carnegie Speech Company, Inc. was founded in 2001 and is based in Pittsburgh, Pennsylvania.

Halfpenny Technologies

Series A in 2012
Halfpenny Technologies, Inc. develops cloud-based healthcare interoperability solutions. It provides clinical data exchange solutions, orders management and computerized provider order entry solutions, business intelligence and notification solutions, and clinical data services. The company’s cloud-based solutions offers vendor-neutral infrastructure that supports care coordination, care management, regulatory requirements, and data analysis within and between healthcare organizations. It serves health plans, accountable care organizations, hospitals, radiology centers, pharmacies, commercial laboratories, population health, care coordination vendors, and HIEs in the United States. The company was founded in 2000 and is based in Blue Bell, Pennsylvania. As of June 14, 2019, Halfpenny Technologies, Inc. operates as a subsidiary of Accumen.

ProtonMedia

Series B in 2011
ProtonMedia is a company that specializes in virtual world technology aimed at enterprise collaboration and learning. Its primary product, ProtoSphere, offers a secure and private environment designed for a range of business applications, including e-learning, virtual meetings, and collaborative events. The platform supports various industries, such as pharmaceuticals, medical devices, financial services, and technology, facilitating rich data visualization and enhancing communication for scientific research, sales, and manufacturing efforts. Founded in 1998 and headquartered in Lansdale, Pennsylvania, ProtonMedia continues to provide innovative solutions that enable organizations to engage effectively in a digital workspace.

Halfpenny Technologies

Series A in 2010
Halfpenny Technologies, Inc. develops cloud-based healthcare interoperability solutions. It provides clinical data exchange solutions, orders management and computerized provider order entry solutions, business intelligence and notification solutions, and clinical data services. The company’s cloud-based solutions offers vendor-neutral infrastructure that supports care coordination, care management, regulatory requirements, and data analysis within and between healthcare organizations. It serves health plans, accountable care organizations, hospitals, radiology centers, pharmacies, commercial laboratories, population health, care coordination vendors, and HIEs in the United States. The company was founded in 2000 and is based in Blue Bell, Pennsylvania. As of June 14, 2019, Halfpenny Technologies, Inc. operates as a subsidiary of Accumen.

InstaMed

Venture Round in 2010
InstaMed Communications, LLC is a healthcare payments network that connects providers, payers, and consumers through a secure, cloud-based platform designed for managing healthcare payment transactions. Founded in 2004 and headquartered in Philadelphia, Pennsylvania, InstaMed offers several products, including InstaMed Online for Providers and InstaMed Online for Payers, both of which ensure secure and efficient management of healthcare payments. Additionally, InstaMed Connect allows for the integration of healthcare payments into various healthcare IT applications through its API. The company's technology enhances the healthcare payment experience by driving electronic transactions and facilitating the seamless movement of funds and healthcare data, ultimately improving consumer satisfaction. As of July 2019, InstaMed operates as a subsidiary of JPMorgan Chase Bank.

ProtonMedia

Series A in 2009
ProtonMedia is a company that specializes in virtual world technology aimed at enterprise collaboration and learning. Its primary product, ProtoSphere, offers a secure and private environment designed for a range of business applications, including e-learning, virtual meetings, and collaborative events. The platform supports various industries, such as pharmaceuticals, medical devices, financial services, and technology, facilitating rich data visualization and enhancing communication for scientific research, sales, and manufacturing efforts. Founded in 1998 and headquartered in Lansdale, Pennsylvania, ProtonMedia continues to provide innovative solutions that enable organizations to engage effectively in a digital workspace.

RedLasso

Venture Round in 2009
Redlasso is a web service that allows users to search TV and radio broadcasts, create clips and share them. On May 20, 2008, it was leaked that RedLasso had been [served](http://www.techcrunch.com/2008/05/20/bloggers-rejoice-customized-tv-clips-with-redlasso/) a Cease and Desist letter from a number of major media organizations. In response, the company [brought on](http://corp.redlasso.com/press/Redlasso-052908-01.pdf) Michael Jordan, former CEO of CBS and Westinghouse Corporation, as a senior advisor.

Avid Radiopharmaceuticals

Series D in 2009
Avid develops molecular imaging agents to aid medical management of chronic human diseases. They are located in Philadelphia, PA. Their mission is to develop new molecular imaging agents capable of changing the medical management of significant, chronic human diseases by identifying the first stages of pathological change, potentially assisting in earlier diagnosis, and better management and development of new therapies.

InstaMed

Venture Round in 2009
InstaMed Communications, LLC is a healthcare payments network that connects providers, payers, and consumers through a secure, cloud-based platform designed for managing healthcare payment transactions. Founded in 2004 and headquartered in Philadelphia, Pennsylvania, InstaMed offers several products, including InstaMed Online for Providers and InstaMed Online for Payers, both of which ensure secure and efficient management of healthcare payments. Additionally, InstaMed Connect allows for the integration of healthcare payments into various healthcare IT applications through its API. The company's technology enhances the healthcare payment experience by driving electronic transactions and facilitating the seamless movement of funds and healthcare data, ultimately improving consumer satisfaction. As of July 2019, InstaMed operates as a subsidiary of JPMorgan Chase Bank.

Carnegie Speech

Series A in 2007
Carnegie Speech Company, Inc., a speech assessment and tutoring software company, provides speech training technology to help to speak English clearly. It offers Carnegie Speech Assessment, which rate the proficiency of spoken English; Native Accent, which teach to pronounce English clearly; and YOUTH Database, a set of recordings of children reading words, phrases, and sentences in English. The company serves BPO and education markets. Carnegie Speech Company, Inc. was founded in 2001 and is based in Pittsburgh, Pennsylvania.

HardMetrics

Series A in 2006
HardMetrics Inc. provides on-demand enterprise business analytics and reporting solutions for call centre driven businesses. The company specializes in optimizing sales, service, and operations by transforming enterprise data into actionable information for effective measurement and precise decision making.

Ceptaris Therapeutics

Series B in 2006
Ceptaris Therapeutics, Inc. is a privately held, specialty pharmaceutical company that is developing a proprietary gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma (CTCL). If approved, Ceptaris' investigational drug would be the first topical mechlorethamine product available to treat the signs and symptoms of this rare cancer.

Melior Discovery

Series A in 2006
Melior Discovery, Inc. develops an in vivo pharmacology platform that identifies novel indications from pre-clinical and development-stage candidates. The company offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal and urology, cardiovascular disease, and dermatology aspects. It serves clients in pharmaceutical and biopharmaceutical industries. The company was founded in 2005 and is based in Exton, Pennsylvania.

Avid Radiopharmaceuticals

Series A in 2006
Avid develops molecular imaging agents to aid medical management of chronic human diseases. They are located in Philadelphia, PA. Their mission is to develop new molecular imaging agents capable of changing the medical management of significant, chronic human diseases by identifying the first stages of pathological change, potentially assisting in earlier diagnosis, and better management and development of new therapies.